Log In
Print
BCIQ
Print
Print this Print this
 

MP0260

  Manage Alerts
Collapse Summary General Information
Company Molecular Partners AG
DescriptionDesigned ankyrin repeat protein (DARPin) that inhibits platelet derived growth factor B (PDGFB; PDF2) and vascular endothelial growth factor A (VEGF-A)
Molecular Target Platelet derived growth factor B (PDGFB) (PDGF2) ; Vascular endothelial growth factor A (VEGF-A)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat wet age-related macular degeneration (AMD)
Regulatory Designation
Partner Allergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$420.0M

$45.0M

$375.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today